as on January 13, 2026 at 10:35 pm IST
Day's Low
Day's High
0.34%
Downside
3.93%
Upside
52 Week's Low
52 Week's High
74.33%
Downside
10.32%
Upside
Check Anaptysbio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
-1.4042
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-5.91
Industry PE ratio
-2.706607142857143
PEG Ratio
0EBITDA
-28.1M
Revenue (TTM)
169.5M
Profit Margin
-49.94%
Return On Equity TTM
-308.02%
Track how Anaptysbio Inc P/E has moved over time to understand its valuation trends.
Anaptysbio Inc in the last 5 years
Lowest (-68.49x)
June 30, 2021
Today (-5.91x)
January 13, 2026
Industry (-2.71x)
January 13, 2026
Highest (90.65x)
September 30, 2021
Today’s Price to Earnings Ratio: -5.91x
Compare market cap, revenue, PE, and other key metrics of Anaptysbio Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.2B | 105.32% | -5.91 | -49.94% | |
| BUY | $52.6B | 117% | 1244.66 | 1.36% | |
| BUY | $118.9B | 102.81% | 32.69 | 31.35% | |
| NA | $37.4B | NA | 662.53 | 1.38% | |
| BUY | $84.4B | 50.03% | 19.08 | 32.13% |
The Anaptysbio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Anaptysbio Inc investment value today
Current value as on today
₹3,29,380
Returns
₹2,29,380
(+229.38%)
Returns from Anaptysbio Inc Stock
₹2,25,308 (+225.31%)
Dollar Returns*
₹4,073 (+4.07%)
Based on 16 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 16 analysts, 75% of analysts recommend a 'BUY' rating for Anaptysbio Inc. Average target price of $66
Get share price movements and forecasts by analysts on Anaptysbio Inc.
What analysts predicted
27.94%UPSIDE
Target Price
$66
Current Price
$47.56
Analyzed by
16 Analysts
Target
$66.00
Anaptysbio Inc target price $66, a slight upside of 27.94% compared to current price of $47.56. According to 16 analysts rating.
Search interest for Anaptysbio Inc Stock has increased by 25% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:25% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 21 November
Fri, 07:16 PM
-AnaptysBio's stock fell 12% after Tesaro announced a lawsuit for alleged breach of license agreement regarding Jemperli.
Fri, 07:18 PM
-Tesaro's lawsuit claims AnaptysBio breached the license agreement for Jemperli, potentially terminating the agreement and reducing payments.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, ANAB stock has moved up by 11.7%
Best in 3 Years
![]()
In the last 3 years, ANAB has outperformed top 5 stocks with highest market-cap in its industry
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -39.32M → 15.11M (in $), with an average increase of 178.7% per quarter
Best in 1 Year
![]()
In the last 1 year, ANAB has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 22.26M → 76.32M (in $), with an average increase of 70.8% per quarter
| Organisation | Anaptysbio Inc |
| Headquarters | 10770 Wateridge Circle, San Diego, CA, United States, 92121-5801 |
| Industry | Health Technology |
| CEO | Mr. Daniel R. Faga |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Eric J. Loumeau | Chief Legal Officer |
Ms. Beth Mueller | Senior Vice President of Human Resources |
Ms. Priya Raina | Senior Vice President of Clinical Operations |
Mr. David McKeon | Senior VP & Controller |
Mr. Daniel R. Faga | President, CEO & Director |
Mr. Dennis M. Mulroy | Chief Financial Officer |
Dr. Paul F. Lizzul FAAD, M.B.A., M.D., M.P.H., Ph.D. | Chief Medical Officer |
Dr. Martin Dahl Ph.D. | Senior Vice President of Research |
Mr. Benjamin Stone | Chief Business Officer |
Ms. Monique Da Silva | Senior Vice President of Corporate Affairs |
Anaptysbio Inc share price today is $47.56 as on . Anaptysbio Inc share today touched a day high of $49.43 and a low of $47.4.
Anaptysbio Inc share touched a 52 week high of $52.47 on and a 52 week low of $12.21 on . Anaptysbio Inc stock price today i.e. is trending at $47.56,which is 9.36% down from its 52 week high and 289.52% up from its 52 week low.
Anaptysbio Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Anaptysbio Inc (ANAB) shares with as little as ₹90.18 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹901.80 in Anaptysbio Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Anaptysbio Inc share’s latest price of $47.56 as on January 13, 2026 at 10:35 pm IST, you will get 0.2103 shares of Anaptysbio Inc. Learn more about
fractional shares .
Anaptysbio Inc stock has given 105.32% share price returns and 23.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?